XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB)

CUSIP: 98386D307

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class
Equity / SPONSORED ADR NE
Total 13F shares
239,879
Total 13F value
$215,794
Share change
-480
SEC-reported price per share
$0.90
Number of holders
4
Value change
-$431
Number of buys
1
Number of sells
1

Security key

98386D307

Report period

Q3 2023

Institutions

4

Top holders

4

XTLB full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 XTL BIOPHARMACEUTICALS LTD SEC filings XTL BIOPHARMACEUTICALS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of XTLB - XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Noked Israel Ltd
Disclosed value leader
Noked Israel Ltd
Comparable rows
0/3
Latest evidence
30 Jun 2023
13F Highest disclosed value: $199,000 3 rows are not safely comparable across share classes.

Quick read

Noked Israel Ltd has the largest disclosed position value at $199K.

0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Noked Israel Ltd's linked filing trail.
Disclosed position value Top 3
Noked Israel Ltd $199K
MORGAN STANLEY $41.2K
BNP PARIBAS FINANCIAL MARKETS $200

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-3 of 3 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Noked Israel Ltd
13F
Company
13F
—
denominator unverified
$199,000
198,888 shares
 — 30 Jun 2023
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$41,167
41,171 shares
 — 30 Jun 2023
BNP PARIBAS FINANCIAL MARKETS
13F
Company
13F
—
denominator unverified
$200
200 shares
 — 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
4
Shares
239,879
Rows available
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q4 2025 Across Filers

Q4 2025 holders
6
Q3 2023 holders
4
Holder diff
-2
Investor Q4 2025 Shares Q3 2023 Shares Share Diff Share Chg % Q4 2025 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .